Calciject 40 CM Solution for Injection

Boric Acid, Calcium, Magnesium

Last verified

Veterinary medicinal product: solution for injection. Distribution category: POM-VPS (Veterinary Medicines Regulations 2013, Schedule 3). Active substance: Boric Acid, Calcium, Magnesium.1

In short: questions and answers

Does Calciject 40 CM Solution for Injection need a prescription?
Status not established. Neither the leaflet nor the law settles how this drug is dispensed, and we do not guess.
Which animals is Calciject 40 CM Solution for Injection for?
Cattle.1
What is the active substance in Calciject 40 CM Solution for Injection?
Boric Acid, Calcium, Magnesium. ATCvet code: QA12AX.13
What is the withdrawal period of Calciject 40 CM Solution for Injection according to the leaflet?
Cattle, meat: 0 days; Cattle, milk: 0 days.3
Dispensing
Status not established

POM-VPS: Prescription Only Medicine - Veterinarian, Pharmacist, Suitably Qualified Person. Prescription only, but the prescription may come from a veterinary surgeon, a pharmacist or a suitably qualified person (SQP, a registered animal-medicine adviser), and they may supply it.12

Animal species
Cattle1
Active substance
Boric Acid, Calcium, Magnesium
ATCvet code
QA12AX3
Manufacturer
Marketing authorisation holder: Norbrook Laboratories Limited

Withdrawal period

Animal speciesProductdays
Cattlemeat03
Cattlemilk03
Summary of product characteristics

Composition

Active Substance:

Contains Calcium Borogluconate40% w/v
Magnesium Hypophosphite Hexahydrate5% w/v

Each 400ml contains :

11.9g calcium (provided by calcium gluconate and calcium borogluconate)

1.85g magnesium (provided by magnesium hypophosphite).

Also contains 6.84% w/v boric acid.

Excipients:

For a full list of excipients, see section 6.1

6.1 List of excipients

Sodium Bicarbonate 10% or Boric Acid 5%

Water for Injections

3

Pharmaceutical form

Solution for Injection A clear pale yellow solution

3

Pharmacological properties

Pharmacotherapeutic group: Mineral Supplements, Calcium, Calcium, combinations with other drugs

ATC Vet Code: QA12AX

5.1 Pharmacodynamic properties

Calcium Borogluconate and Magnesium Hypophosphite are soluble salts of calcium and magnesium respectively used extensively in fluid infusions in correction of metabolic disturbances. On parenteral administration they rapidly increase plasma concentrations of calcium, magnesium and phosphorus. This is effective in the treatment of hypocalcaemia with associated magnesium and phosphorus deficiencies.

3

Target species

Cattle

3

Indications

Indicated in the treatment of hypocalcaemia in cattle where increased blood magnesium levels are required.

3

Dosage

Administer by subcutaneous or slow intravenous injection

Cattle: 200 to 400 ml

3

Contraindications

None

3

Adverse reactions

Occasional temporary swelling may occur at sites of subcutaneous administration.

3

Warnings

i. Special precautions for use in animals

The solution should be warmed to body temperature before administration. Intravenous injections should be given slowly in order to avoid possible neuromuscular dysfunction and cardiac insufficiency. Normal aseptic precautions should be observed.

Sites of subcutaneous administration should be massaged gently.

ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals

Care should be taken to avoid accidental self-injection: may cause irritation at site of injection.

3

Use during pregnancy, lactation or lay

Safe for use during pregnancy and lactation

3

Interactions

None

3

Overdose

Not applicable.

3

Special warnings

None

3

Withdrawal period

Cattle

Meat : Zero Days

Milk : Zero Hours

3

Incompatibilities

None known

3

Immediate packaging

Marketed in either 400 ml Amber Type III glass vials sealed using black rubber wads and aluminium screw caps, or 400ml polypropylene containers sealed with bromobutyl bungs and aluminium caps.

3

Storage

Do not store above 25oC. Protect from light.

The product does not contain an antimicrobial preservative. The product is intended for single use only. Any product remaining in the bottle after withdrawal of the required dose should be discarded.

3

Shelf life

Shelf life of the veterinary medicinal product as packaged for sale; Glass bottles: 2 years Polypropylene vials: 18 months

3

Disposal of unused product

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

3

Additional information

Vm 02000/4125

9 DATE OF FIRST AUTHORISATION

5th July 1994

10 DATE OF REVISION OF THE TEXT

July 2010

3

Registration holder

Norbrook Laboratories Limited

Station Works

Camlough Road

NEWRY

Co. Down, BT35 6JP

Northern Ireland

3

Regulations

Sources

  1. VMD Product Information Database: Calciject 40 CM Solution for Injection, 02000/4125 UK Veterinary Medicines Directorate (OGL v3.0), checked 2026-10-04 archived copy from 2026-10-04
  2. The Veterinary Medicines Regulations 2013, Schedule 3 (categories of veterinary medicinal products) UK Government, legislation.gov.uk, checked 2026-10-04 archived copy from 2026-10-04
  3. Summary of Product Characteristics: Calciject 40 CM Solution for Injection UK Veterinary Medicines Directorate, SPC of the marketing authorisation holder, checked 2026-10-04 archived copy from 2026-10-04